The Queen Elizabeth Hospital King’s Lynn NHS Foundation Trust has been awarded more than £215,000 to purchase a new cutting-edge 4D cardiac ultrasound machine, which will expand scope and innovation of clinical research at the hospital.

Using the latest technologies researchers have uncovered novel candidate drug targets for non-alcoholic fatty liver disease.

Immunologists have uncovered a key pathogenic event prompted by obesity that can trigger severe forms of non alcoholic fatty liver disease and potential liver failure.

In a new study, researchers found first-degree relatives of patients with NAFLD characterised by advanced fibrosis are at a 15 per cent risk of developing the condition.

All health and care staff should receive training in artificial intelligence (AI) with additional specialist training for those who use AI tools in clinical practice, according to new research published this week.